{
    "nctId": "NCT04720508",
    "briefTitle": "Aberrant Expression of Micro RNA for Diagnosis of Breast Cancer",
    "officialTitle": "Aberrant Expression of Circulating Micro RNA as a Biomarker for Diagnosis of Breast Cancer in Egyptian Females",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 50,
    "primaryOutcomeMeasure": "Assess serum miRNA-373 and miRNA-425-5p expression in patients with breast cancer.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female age 20 years or older\n* documented diagnosis of breast cancer based on physical examination, imaging and histopathology\n* possibility of obtaining blood samples from the subject.\n\nExclusion Criteria:\n\n* All patients with prior history of exposure to chemotherapy, radiotherapy or hormonal therapy .\n* patients with other malignancies.\n* patients with chronic inflammatory diseases.\n* patients with missed documentation for histopathological diagnosis of breast cancer.",
    "sex": "FEMALE",
    "minimumAge": "20 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}